Heart transplantation in patients with hypertrophic cardiomyopathy

Marta Farrero Torres, Felix Perez-Villa


[first paragraph of article]

Hypertrophic cardiomyopathy has a broad spectrum of clinical presentations, from asymptomatic to patients with advanced heart failure and sudden death. Treatment options are limited, especially in non-obstructive forms. A minority of patients (around 3.5%) can progress to an end-stage state, characterized by systolic dysfunction and restrictive ventricular filling, related to extensive fibrotic replacement and chamber remodeling. In these cases, life expectancy is significantly reduced: a mean 3-year survival time has been reported.

Full Text:


DOI: http://dx.doi.org/10.21542/gcsp.2018.32


  • There are currently no refbacks.

Copyright (c) 2018 Marta Farrero Torres, Felix Perez-Villa

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.